Diagnosed with triple-negative breast cancer at age 36 and now in remission, gynecological oncologist Deanna Gerber, M.D., says her experience has made her a better physician and advocate for her patients.

Discover groundbreaking research on hard-to-treat skin conditions like hidradenitis suppurativa and vitiligo at the EADV 2025 Congress in Paris.

A decline in PrEP coverage could reverse HIV prevention gains, causing tens of thousands of preventable infections and billions in added healthcare costs, a new JAMA Network Open study finds.

CT-155, an AI-powered smartphone app, addresses an unmet need in schizophrenia, showing safety and efficacy in a phase 3 trial.

The FDA's groundbreaking decision to waive clinical efficacy studies for a monoclonal antibody biosimilar revolutionizes drug approval, reducing costs and enhancing patient access.

Two separate analyses in Health Affairs find the One Big Beautiful Bill creates a loophole that exempts or delays orphan drugs — many of them blockbuster drugs that generate billions of dollars in sales — from price negotiations.

Parents are facing mixed messages on back-to-school vaccines, with David Dodd of GeoVax urging families to prioritize required school shots first, then flu and RSV, while weighing COVID-19 decisions with their pediatrician amid conflicting federal and pediatric guidance.

The new JAMA + Women’s Health multimedia channel focuses on all aspects of women’s health, not just topics like menopause or ovarian cancer, presenting content from across JAMA and JAMA Network in one place.

A dissolvable microneedle patch delivering doxorubicin shows encouraging efficacy in a phase 2 trial to treat patients with basal cell carcinoma.

Disparities emerged in receipt of systemic therapy, particularly in lung cancer.

Provider-sponsored health plans thrive in the evolving ACA market, offering trusted, community-based coverage and efficient care coordination as major insurers exit.

Use of transparent PBMs has surged as employer reliance on the Big Three declines, highlighting shifting strategies to address escalating healthcare costs, the Pulse of the Purchaser 2025 survey finds.

Ongoing research is needed to further explore the best methods for anal cancer detection in people living with HIV, according to a recent review.

A new prognostic tool combines albumin-prealbumin-globulin ratio and mid-arm circumference to enhance gastric cancer risk stratification and improve patient outcomes.

ICER’s comparative effectiveness and value review of Wegovy, Zepbound and oral semaglutide finds they are highly effective treatments with significant health benefits, but affordability and long-term management are still unresolved.

Vaccination reduced the risk of heart attack and stroke as well as the risk of herpes zoster ophthalmicus,

For someone with HIV, a mental health disorder may decrease their life expectancy by as many as five years, according to the results of a recent international study.

Early immune aging signals emerge in individuals at risk for rheumatoid arthritis, highlighting potential pathways for early intervention and disease prevention.

Patients had a lower risk of dementia if they were vaccinated against shingles or respiratory syncytial virus, but not if they only had a flu vaccine.

Panelists at a session at the Pharmacy Benefit Management Institute’s annual meeting in Orlando discussed how stop-loss insurance addresses rising costs from cell therapies, oncology treatments, and orphan drugs affecting self-funded employer plans.

Serge Perras, MBA, says AI has made a meaningful difference in medication therapy management processes at Abarca, but he warned against repeating the overexuberance about technology for its own sake that led to the dot-com boom and bust.

In a wide-ranging interview, the chief medical officer of the SCAN Group discusses primary care, SCAN's partnership with Sutter and the way healthcare is practiced on the West Coast compared with the East Coast.

For 60 years, community health centers have provided care in the nation’s disadvantaged neighborhoods and communities, largely outside of the limelight. Now, Medicaid and other funding cutbacks threaten their future.

Employers are shopping around, according to panelists at a session at the 2025 PBMI meeting in Orlando. Transparency and a "true partnership" are among the attributes they are looking for.